Updated May 11, 2022
Go to the JCI's conflict-of-interest policy
AbbVie (A.B. Heimberger)
AccureX (D. Krainc)
Actuate Therapeutics (S.A. Abdulkadir)
Arvinas (M. Hussain)
Astellas Pharma (S.A, Abdulkadir)
AstraZeneca (M. Hussain)
Bayer (M. Hussain)
Boehringer Ingelheim (G.D. Barish)
Caris Life Sciences (A.B. Heimberger)
Celularity (A.B. Heimberger)
Codiak (A.B. Heimberger)
Genentech (M. Hussain)
Google (J. Choi)
Inomagen Therapeutics Inc. (R. Arora)
Intellia Therapeutics (D. Krainc)
Ionis (J. Bass)
Intellia Therapeutics (D. Krainc)
Mannin Research Inc. (S.E. Quaggin)
Medtronic (J. Bass)
Merck (A.B. Heimberger)
Nfold (S. Eisenbarth)
OrbiMed Advisors (D. Krainc)
Parexel (S. Bulun)
Pfizer (N.S. Chandel)
Praxis Precision Medicines (A.L. George Jr.)
Rafael Pharmaceuticals (N.S. Chandel)
Regeneron (J. Bass)
Roche (S.E. Quaggin)
Tevard Biosciences (A.L. George Jr.)
Thermo Fisher Scientific (J. Bass)
Vertex (J. Bass)
Vortex Biosciences (S.A, Abdulkadir)
WCG (A.B. Heimberger)
Yumanity Therapeutics (A.B. Heimberger)
Vanqua Bio (D. Krainc)